PACS Group, Valuation
| PACS Stock | 13.35 0.42 3.25% |
At this time, the entity appears to be overvalued. PACS Group, owns a latest Real Value of USD12.82 per share. The recent price of the entity is USD13.35. Our model determines the value of PACS Group, from evaluating the entity fundamentals such as shares outstanding of 155.18 M, and Operating Margin of 0.0007 % as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that PACS Group,'s price fluctuation is slightly risky at this time. Calculation of the real value of PACS Group, is based on 3 months time horizon. Increasing PACS Group,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PACS stock is determined by what a typical buyer is willing to pay for full or partial control of PACS Group,. Since PACS Group, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PACS Stock. However, PACS Group,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.35 | Real 12.82 | Hype 13.35 | Naive 12.54 |
The intrinsic value of PACS Group,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PACS Group,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PACS Group, helps investors to forecast how PACS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PACS Group, more accurately as focusing exclusively on PACS Group,'s fundamentals will not take into account other important factors: PACS Group, Total Value Analysis
PACS Group, is at this time forecasted to have valuation of 8.92 B with market capitalization of 6.32 B, debt of 2.85 B, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PACS Group, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.92 B | 6.32 B | 2.85 B |
PACS Group, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of PACS implies not a very effective usage of assets in January.PACS Group, Ownership Allocation
PACS Group, secures a total of 155.18 Million outstanding shares. PACS Group, owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.76 % of PACS Group, outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that around six million six hundred seventy-two thousand six hundred fifty-four invesors are currently shorting PACS Group, expressing very little confidence in its future performance.PACS Group, Profitability Analysis
The company reported the previous year's revenue of 3.11 B. Net Income was 112.87 M with profit before overhead, payroll, taxes, and interest of 0.About PACS Group, Valuation
The stock valuation mechanism determines PACS Group,'s current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of PACS Group, based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of PACS Group,. We calculate exposure to PACS Group,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PACS Group,'s related companies.PACS Group, Growth Indicators
Investing in growth stocks can be very risky. If the company such as PACS Group, does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 150.2 M | |
| Forward Price Earnings | 21.3675 |
Additional Tools for PACS Stock Analysis
When running PACS Group,'s price analysis, check to measure PACS Group,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS Group, is operating at the current time. Most of PACS Group,'s value examination focuses on studying past and present price action to predict the probability of PACS Group,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS Group,'s price. Additionally, you may evaluate how the addition of PACS Group, to your portfolios can decrease your overall portfolio volatility.